A1EEG: (6~{S},9~{a}~{S})-6-(2-methylpropyl)-8-(naphthalen-1-ylmethyl)-4,7-bis(oxidanylidene)-~{N}-(phenylmethyl)-3,6,9,9~{a}-tetrahydro-2~{H}-pyrazino[1,2-a]pyrimidine-1-carboxamide
A1EEG is a Ligand Of Interest in 9K2K designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9K2K_A1EEG_B_301 | 68% | 11% | 0.085 | 0.937 | 2.75 | 1.5 | 14 | 7 | 2 | 0 | 100% | 1 |
| 9K2K_A1EEG_J_301 | 64% | 11% | 0.091 | 0.927 | 2.86 | 1.32 | 15 | 5 | 0 | 0 | 100% | 1 |
| 9K2K_A1EEG_I_301 | 63% | 12% | 0.093 | 0.925 | 2.77 | 1.36 | 14 | 7 | 1 | 0 | 100% | 1 |
| 9K2K_A1EEG_G_301 | 62% | 10% | 0.093 | 0.922 | 2.78 | 1.49 | 13 | 5 | 0 | 0 | 100% | 1 |
| 9K2K_A1EEG_K_301 | 59% | 10% | 0.103 | 0.922 | 2.91 | 1.46 | 12 | 6 | 0 | 0 | 100% | 1 |
| 9K2K_A1EEG_F_301 | 58% | 11% | 0.104 | 0.921 | 2.76 | 1.47 | 13 | 6 | 0 | 0 | 100% | 1 |
| 9K2K_A1EEG_A_301 | 58% | 12% | 0.097 | 0.908 | 2.64 | 1.4 | 14 | 7 | 1 | 0 | 100% | 1 |
| 9K2K_A1EEG_C_301 | 58% | 12% | 0.104 | 0.918 | 2.77 | 1.29 | 13 | 7 | 0 | 0 | 100% | 1 |
| 9K2K_A1EEG_E_301 | 57% | 9% | 0.104 | 0.916 | 2.89 | 1.66 | 12 | 8 | 3 | 0 | 100% | 1 |
| 9K2K_A1EEG_D_301 | 57% | 12% | 0.101 | 0.909 | 2.65 | 1.43 | 14 | 10 | 1 | 0 | 100% | 1 |
| 9K2K_A1EEG_H_301 | 57% | 10% | 0.103 | 0.912 | 2.91 | 1.44 | 12 | 5 | 3 | 0 | 100% | 1 |
| 9K2K_A1EEG_N_301 | 52% | 2% | 0.113 | 0.904 | 5.74 | 1.33 | 14 | 8 | 7 | 0 | 100% | 1 |
| 9K2K_A1EEG_L_301 | 49% | 2% | 0.122 | 0.908 | 5.49 | 1.66 | 16 | 5 | 6 | 0 | 100% | 1 |
| 9K2K_A1EEG_M_301 | 44% | 2% | 0.125 | 0.886 | 5.65 | 1.3 | 15 | 5 | 4 | 0 | 100% | 1 |